A global platform for translational medicine, guided by scientific integrity and international collaboration.
The Norman Bethune International Institute of Canada for Healthcare Innovation (NBIIC-HI) is an independent research platform based in Canada, dedicated to advancing translational medicine and global healthcare innovation.
Established to promote interdisciplinary dialogue and mechanism-informed translational research, the Institute serves as a collaborative platform connecting scientific discovery with clinical advancement.
Guided by scientific excellence, transparency, and long-term institutional responsibility, the Institute is committed to contributing to responsible innovation and the sustainable advancement of healthcare.
Chen Deng is the Founder and Executive Director of the Norman Bethune International Institute of Canada for Healthcare Innovation (NBIIC-HI), a Canada-based platform dedicated to advancing mechanism-driven translational medicine, global healthcare innovation, and interdisciplinary collaboration.
Inspired by the Norman Bethune spirit of dedication, compassion, and scientific excellence, he works to connect researchers, clinicians, healthcare institutions, innovation platforms, and industry partners worldwide. Through NBIIC-HI, he supports international research collaboration, joint grant development, strategic project design, healthcare service initiatives, talent development, and cross-border healthcare innovation.
Advancing mechanism-informed translational research.
Fostering international academic partnerships.
Integrating clinical insight and scientific knowledge.
Committed to transparency and responsible research conduct.
Facilitating international funding applications, project development, and collaborative research initiatives.
Supporting academic exchange, scholarship opportunities, and early-career researcher training.
The mission of NBIIC-HI is to bridge scientific discovery and clinical advancement by fostering mechanism-informed translational research, interdisciplinary collaboration, and responsible international partnership.
Through interdisciplinary dialogue and evidence-based innovation, the Institute advances ethically grounded partnerships that contribute to sustainable healthcare development. It is committed to responsible research and meaningful international collaboration.
NBIIC-HI supports international academic exchange, early-career researcher development, and scholarship-based training opportunities in healthcare innovation, with the goal of fostering future leaders in translational medicine and global healthcare innovation.
NBIIC-HI advances translational medicine through an integrated and collaborative research framework centered on mechanism-informed strategies and clinical relevance.
Connecting disease regulatory mechanisms with therapeutic innovation pathways.
Bridging experimental discovery with real-world clinical application.
Targeting key regulatory networks within complex disease systems.
Developing precision-oriented intervention strategies.
Enabling structured international partnerships and knowledge exchange.
Integrating bioinformatics, multi-omics analysis, and meta-analysis to uncover regulatory mechanisms and support translational research.
Current research initiatives are structured around mechanism-driven translational strategies, integrating experimental, clinical, computational, and therapeutic approaches across complex disease systems.
Mechanism-informed translational research across oncology, metabolic, and complex diseases.
Clinical-integrated research frameworks for precision healthcare.
Immunoregulation and disease microenvironment remodeling.
Targeted delivery strategies and therapeutic system development.
Computational biology and data-driven discovery integrating bioinformatics, multi-omics analysis, and meta-analysis.
International collaborative research initiatives supported by clinical partnerships and national-level funding programs.
Selected peer-reviewed publications reflecting the Institute's translational research focus in 2026.These studies exemplify the Institute’s approach to mechanism-driven translational research, integrating immunoregulation, microenvironment modulation, and targeted delivery strategies.
International Immunopharmacology. 2026. View on PubMed
Cancer Cell International. 2026. View on PubMed
These studies exemplify the Institute's approach to mechanism-driven translational research, integrating immunoregulation, microenvironment modulation, and targeted delivery strategies.
NBIIC-HI operates under a mission-driven governance framework grounded in academic integrity, transparency, and scientific accountability. Strategic direction and collaborative initiatives are guided by responsible research principles and aligned with international best practices.
All governance practices are guided by responsible research principles and aligned with international best practices.
NBIIC-HI develops international research programs through academic partnerships, interdisciplinary collaboration, and translational innovation.
Our programs focus on advancing responsible, evidence-based healthcare research across global networks, connecting scientific expertise with clinical needs.
Explore Research Programs
The Institute brings together a global network of leading experts across clinical medicine, biomedical research, and translational science..
Our expert network spans North America, Europe, and Asia, including internationally recognized researchers and clinicians from top institutions such as McGill University, the University of Cambridge, Cornell University, Shanghai Jiao Tong University, and the University of Tokyo.
Through this network, NBIIC-HI enables high-level collaboration, interdisciplinary knowledge exchange, and the development of innovative translational research initiatives.
All collaborations are guided by rigorous scientific standards, clinical relevance, and a shared commitment to advancing responsible and impactful healthcare solutions worldwide.
Connecting global expertise to accelerate translational impact.
The Institute welcomes inquiries and collaboration opportunities from researchers, academic institutions, and healthcare professionals worldwide.
Trillium Executive Centre
Greater Toronto Area, Ontario L3R 0B8
Canada
We welcome applications from researchers, clinicians, and institutions interested in collaboration or membership. Selected applicants may be invited for further academic collaboration or project development discussions.
To apply, please download and complete the application form and submit it via email.
Download Application FormSubmission: admin@nbiic.ca
Applications are reviewed on a rolling basis.
Note: All inquiries will be reviewed and responded to in accordance with the Institute's communication policies.
